BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34256850)

  • 1. Coding and noncoding variants in EBF3 are involved in HADDS and simplex autism.
    Padhi EM; Hayeck TJ; Cheng Z; Chatterjee S; Mannion BJ; Byrska-Bishop M; Willems M; Pinson L; Redon S; Benech C; Uguen K; Audebert-Bellanger S; Le Marechal C; Férec C; Efthymiou S; Rahman F; Maqbool S; Maroofian R; Houlden H; Musunuri R; Narzisi G; Abhyankar A; Hunter RD; Akiyama J; Fries LE; Ng JK; Mehinovic E; Stong N; Allen AS; Dickel DE; Bernier RA; Gorkin DU; Pennacchio LA; Zody MC; Turner TN
    Hum Genomics; 2021 Jul; 15(1):44. PubMed ID: 34256850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical spectrum of individuals with de novo EBF3 variants or deletions.
    Nishi E; Uehara T; Yanagi K; Hasegawa Y; Ueda K; Kaname T; Yamamoto T; Kosaki K; Okamoto N
    Am J Med Genet A; 2021 Oct; 185(10):2913-2921. PubMed ID: 34050706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo variants in
    Tanaka AJ; Cho MT; Willaert R; Retterer K; Zarate YA; Bosanko K; Stefans V; Oishi K; Williamson A; Wilson GN; Basinger A; Barbaro-Dieber T; Ortega L; Sorrentino S; Gabriel MK; Anderson IJ; Sacoto MJG; Schnur RE; Chung WK
    Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.
    Chao HT; Davids M; Burke E; Pappas JG; Rosenfeld JA; McCarty AJ; Davis T; Wolfe L; Toro C; Tifft C; Xia F; Stong N; Johnson TK; Warr CG; ; Yamamoto S; Adams DR; Markello TC; Gahl WA; Bellen HJ; Wangler MF; Malicdan MCV
    Am J Hum Genet; 2017 Jan; 100(1):128-137. PubMed ID: 28017372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders.
    Gillentine MA; Wang T; Hoekzema K; Rosenfeld J; Liu P; Guo H; Kim CN; De Vries BBA; Vissers LELM; Nordenskjold M; Kvarnung M; Lindstrand A; Nordgren A; Gecz J; Iascone M; Cereda A; Scatigno A; Maitz S; Zanni G; Bertini E; Zweier C; Schuhmann S; Wiesener A; Pepper M; Panjwani H; Torti E; Abid F; Anselm I; Srivastava S; Atwal P; Bacino CA; Bhat G; Cobian K; Bird LM; Friedman J; Wright MS; Callewaert B; Petit F; Mathieu S; Afenjar A; Christensen CK; White KM; Elpeleg O; Berger I; Espineli EJ; Fagerberg C; Brasch-Andersen C; Hansen LK; Feyma T; Hughes S; Thiffault I; Sullivan B; Yan S; Keller K; Keren B; Mignot C; Kooy F; Meuwissen M; Basinger A; Kukolich M; Philips M; Ortega L; Drummond-Borg M; Lauridsen M; Sorensen K; Lehman A; ; Lopez-Rangel E; Levy P; Lessel D; Lotze T; Madan-Khetarpal S; Sebastian J; Vento J; Vats D; Benman LM; Mckee S; Mirzaa GM; Muss C; Pappas J; Peeters H; Romano C; Elia M; Galesi O; Simon MEH; van Gassen KLI; Simpson K; Stratton R; Syed S; Thevenon J; Palafoll IV; Vitobello A; Bournez M; Faivre L; Xia K; ; Earl RK; Nowakowski T; Bernier RA; Eichler EE
    Genome Med; 2021 Apr; 13(1):63. PubMed ID: 33874999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of clinical features and EBF3 gene variant in a child with hypotonia, ataxia and developmental delay].
    Cong Y; Wang D; Wang H; Xu X; Wu K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1270-1274. PubMed ID: 36317217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo variants in neurodevelopmental disorders with epilepsy.
    Heyne HO; Singh T; Stamberger H; Abou Jamra R; Caglayan H; Craiu D; De Jonghe P; Guerrini R; Helbig KL; Koeleman BPC; Kosmicki JA; Linnankivi T; May P; Muhle H; Møller RS; Neubauer BA; Palotie A; Pendziwiat M; Striano P; Tang S; Wu S; ; Poduri A; Weber YG; Weckhuysen S; Sisodiya SM; Daly MJ; Helbig I; Lal D; Lemke JR
    Nat Genet; 2018 Jul; 50(7):1048-1053. PubMed ID: 29942082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism.
    Harms FL; Girisha KM; Hardigan AA; Kortüm F; Shukla A; Alawi M; Dalal A; Brady L; Tarnopolsky M; Bird LM; Ceulemans S; Bebin M; Bowling KM; Hiatt SM; Lose EJ; Primiano M; Chung WK; Juusola J; Akdemir ZC; Bainbridge M; Charng WL; Drummond-Borg M; Eldomery MK; El-Hattab AW; Saleh MAM; Bézieau S; Cogné B; Isidor B; Küry S; Lupski JR; Myers RM; Cooper GM; Kutsche K
    Am J Hum Genet; 2017 Jan; 100(1):117-127. PubMed ID: 28017373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urologic manifestations of hypotonia, ataxia, and delayed development syndrome (HADDS), a rare neurodevelopmental disorder.
    Batie SF; Ashbrook CQ; Coco CT; Baker LA; Stanasel I
    J Pediatr Urol; 2023 Dec; 19(6):751.e1-751.e9. PubMed ID: 37718233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of De Novo Noncoding Regulatory Mutations in Neurodevelopmental Disorders.
    Turner TN; Eichler EE
    Trends Neurosci; 2019 Feb; 42(2):115-127. PubMed ID: 30563709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonrandom occurrence of multiple de novo coding variants in a proband indicates the existence of an oligogenic model in autism.
    Du Y; Li Z; Liu Z; Zhang N; Wang R; Li F; Zhang T; Jiang Y; Zhi X; Wang Z; Wu J
    Genet Med; 2020 Jan; 22(1):170-180. PubMed ID: 31332282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant recurrence in neurodevelopmental disorders: the use of publicly available genomic data identifies clinically relevant pathogenic missense variants.
    Lecoquierre F; Duffourd Y; Vitobello A; Bruel AL; Urteaga B; Coubes C; Garret P; Nambot S; Chevarin M; Jouan T; Moutton S; ; Tran-Mau-Them F; Philippe C; Sorlin A; Faivre L; Thauvin-Robinet C
    Genet Med; 2019 Nov; 21(11):2504-2511. PubMed ID: 31036916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism.
    Chen R; Davis LK; Guter S; Wei Q; Jacob S; Potter MH; Cox NJ; Cook EH; Sutcliffe JS; Li B
    Mol Autism; 2017; 8():14. PubMed ID: 28344757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated gene analyses of de novo variants from 46,612 trios with autism and developmental disorders.
    Wang T; Kim CN; Bakken TE; Gillentine MA; Henning B; Mao Y; Gilissen C; ; Nowakowski TJ; Eichler EE
    Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2203491119. PubMed ID: 36350923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic analyses implicate noncoding de novo variants in congenital heart disease.
    Richter F; Morton SU; Kim SW; Kitaygorodsky A; Wasson LK; Chen KM; Zhou J; Qi H; Patel N; DePalma SR; Parfenov M; Homsy J; Gorham JM; Manheimer KB; Velinder M; Farrell A; Marth G; Schadt EE; Kaltman JR; Newburger JW; Giardini A; Goldmuntz E; Brueckner M; Kim R; Porter GA; Bernstein D; Chung WK; Srivastava D; Tristani-Firouzi M; Troyanskaya OG; Dickel DE; Shen Y; Seidman JG; Seidman CE; Gelb BD
    Nat Genet; 2020 Aug; 52(8):769-777. PubMed ID: 32601476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duplication/triplication mosaicism of EBF3 and expansion of the EBF3 neurodevelopmental disorder phenotype.
    Ignatius E; Puosi R; Palomäki M; Forsbom N; Pohjanpelto M; Alitalo T; Anttonen AK; Avela K; Haataja L; Carroll CJ; Lönnqvist T; Isohanni P
    Eur J Paediatr Neurol; 2022 Mar; 37():1-7. PubMed ID: 34999443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel de novo variant in
    Blackburn PR; Barnett SS; Zimmermann MT; Cousin MA; Kaiwar C; Pinto E Vairo F; Niu Z; Ferber MJ; Urrutia RA; Selcen D; Klee EW; Pichurin PN
    Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001743. PubMed ID: 28487885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three generation families: Analysis of de novo variants in autism.
    Costa CIS; da Silva Campos G; da Silva Montenegro EM; Wang JYT; Scliar M; Monfardini F; Zachi EC; Lourenço NCV; Chan AJS; Pereira SL; Engchuan W; Thiruvahindrapuram B; Zarrei M; Scherer SW; Passos-Bueno MR
    Eur J Hum Genet; 2023 Sep; 31(9):1017-1022. PubMed ID: 37280359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-Based Analysis of De Novo Variants in Neurodevelopmental Disorders.
    Turner TN; Wilfert AB; Bakken TE; Bernier RA; Pepper MR; Zhang Z; Torene RI; Retterer K; Eichler EE
    Am J Hum Genet; 2019 Dec; 105(6):1274-1285. PubMed ID: 31785789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo Truncating Variants in the Last Exon of SEMA6B Cause Progressive Myoclonic Epilepsy.
    Hamanaka K; Imagawa E; Koshimizu E; Miyatake S; Tohyama J; Yamagata T; Miyauchi A; Ekhilevitch N; Nakamura F; Kawashima T; Goshima Y; Mohamed AR; Ch'ng GS; Fujita A; Azuma Y; Yasuda K; Imamura S; Nakashima M; Saitsu H; Mitsuhashi S; Mizuguchi T; Takata A; Miyake N; Matsumoto N
    Am J Hum Genet; 2020 Apr; 106(4):549-558. PubMed ID: 32169168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.